RIVASTIGMINE 13.3 MG/24HR PTCH

rivastigmine
$1.9469per EA

Strength

13.3 mg/24h

NDC

00378907293

Classification

Generic

Dosage Form

PATCH

Route

TRANSDERMAL

Last Updated

4/22/2026

Active Ingredients

RIVASTIGMINE

Approval Type

Generic (ANDA)

FDA Application

ANDA205622

On Market Since

6/20/2018

Pharmacological Classes

Cholinesterase Inhibitor
Cholinesterase Inhibitors

Price History

1W

0.0%

1M

-5.6%

3M

-0.7%

6M

+0.8%

1Y

-2.7%

3Y

-19.2%

5Y

-51.1%

All

-70.6%